Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Department of Justice
Teva
Healthtrust
Argus Health
Daiichi Sankyo
McKinsey
Federal Trade Commission
Fish and Richardson
Colorcon

Generated: October 17, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,753,618

« Back to Dashboard

Summary for Patent: 5,753,618

Title: Somatostatin analogue composition and use in treating breast cancer
Abstract:The invention provides a pharmaceutical composition containing a somatostatin analogue, and its use in the treatment of breast cancer. The pharmaceutical composition preferably contains lactic acid in addition to the somatostatin analogue and is better tolerated when administered by injection.
Inventor(s): Cavanak; Thomas (Biel-Benken, CH), Harris; Alan (Basel, CH)
Assignee: Novartis Corporation (Summit, NJ)
Application Number:08/471,706
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Use;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,753,618

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8716324Jul 10, 1987
United Kingdom8716326Jul 10, 1987

International Patent Family for Patent: 5,753,618

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Greece1000172► Subscribe
Greece880100458► Subscribe
United Kingdom8716326► Subscribe
United Kingdom8716324► Subscribe
United Kingdom2239178► Subscribe
United Kingdom2208200► Subscribe
United Kingdom9027324► Subscribe
United Kingdom8816024► Subscribe
France2617714► Subscribe
Finland93308► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
QuintilesIMS
Chubb
Citi
Cantor Fitzgerald
Daiichi Sankyo
AstraZeneca
US Department of Justice
Deloitte
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot